agilon health (NYSE:AGL) Trading Down 5.3% – Here’s What Happened

agilon health, inc. (NYSE:AGL)’s share price fell 5.3% during trading on Thursday . The stock traded as low as $4.15 and last traded at $4.17. 1,123,403 shares were traded during mid-day trading, a decline of 80% from the average session volume of 5,738,973 shares. The stock had previously closed at $4.40.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Sanford C. Bernstein boosted their target price on shares of agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a research note on Wednesday, January 15th. Royal Bank of Canada lifted their price target on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research note on Wednesday, February 26th. Citigroup raised agilon health from a “sell” rating to a “neutral” rating and upped their price target for the stock from $1.75 to $2.25 in a report on Friday, January 10th. Needham & Company LLC restated a “hold” rating on shares of agilon health in a research report on Friday. Finally, Macquarie started coverage on agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 price objective on the stock. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $3.95.

agilon health Price Performance

The company has a market capitalization of $1.86 billion, a PE ratio of -4.80 and a beta of 0.67. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a fifty day simple moving average of $3.51 and a 200-day simple moving average of $2.95.

Hedge Funds Weigh In On agilon health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Capital International Investors boosted its holdings in shares of agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock valued at $42,431,000 after buying an additional 9,346,295 shares in the last quarter. Millennium Management LLC lifted its position in agilon health by 187.8% in the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after acquiring an additional 4,706,357 shares during the last quarter. Citigroup Inc. boosted its stake in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares in the last quarter. Algert Global LLC grew its holdings in shares of agilon health by 1,042.7% during the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock worth $4,007,000 after purchasing an additional 1,924,157 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in shares of agilon health by 49.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock worth $8,629,000 after purchasing an additional 1,498,524 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.